MVP — Medical Developments International Cashflow Statement
0.000.00%
- AU$52.39m
- AU$36.91m
- AU$33.15m
- 62
- 59
- 70
- 69
Annual cashflow statement for Medical Developments International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.358 | 0.044 | 0.14 | 0.784 | 0.336 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 0.172 | -8.89 | -10.8 | -16.5 | -10.8 |
Capital Expenditures | -8.9 | -6.56 | -5.21 | -7.67 | -3.17 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.429 | 0.082 | 0.055 | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -8.47 | -6.48 | -5.16 | -7.67 | -3.17 |
Financing Cash Flow Items | -0.013 | -0.727 | -0.003 | -1.68 | -0.533 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.97 | 36.1 | 0.142 | 28.1 | -0.807 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.1 | 20.7 | -15.9 | 4.26 | -14.9 |